Patient Enrollment Commences in Bioenvision&#39;s US Prostate
101829
NEW YORK - (BUSINESS WIRE) â-ept. 23, 2004 â -envision (Nasdaq:BIVN) today announced that the first patients have been enrolled at the Massachusetts General Hospital, Boston in a clinical study of
338564
Doctors need to develop a more organized team approach to prostate cancer, with a clear outline on how to screen for the disease and to
159003
Scientists have found a new way to identify a particularly deadly form of prostate cancer in a breakthrough that could save tens of thousands of men from undergoing unnecessary surgery each year.
291208
Researchers anticipate a major recruiting effort and construction boom as California&#39;s new stem-cell experiment gets under way, creating what amounts to an independent West Coast version of the National Institutes of Health.
438501
Here's what a newly approved drug looks like.
471781
The company is ready to handle competition from generics.
284883
James brown, underwent the surgery to treat his cancer yesterday recently diagnosed prostate, and its forecast is good. &quot;we expect a full re-establishment,&quot; said Dr.
731145
Science & environment: Objective of growing replacement organs for humans has been brought a step closer
519863
The company faces a pivotal clinical trial.
344017
One in six American men will be diagnosed with prostate cancer this year. It&#39;s a more common disease among men than breast cancer is among women.
683607
AtheroGenics announces the path forward for its lead drug.
602881
Men with prostate cancer who have to wait up to three months after diagnosis to receive external-beam radiation therapy don&#39;t have worse outcomes than men who start treatment
203814
The first clinical trial of the herbal supplement Zyflamend in patients with a precursor to prostate cancer is being conducted by researchers at Columbia University Medical Center in New York City.
520436
Using the largest known prostate cancer data set of patients treated solely with external-beam radiation in the US, radiation oncologists have examined the &quot;PSA bounce&quot; phenomenon and determined that it is not an indicator that men will die of prostate
494020
Big opportunities await patient investors in nanotech, cleantech, and robotics.
364686
Bioenvision Inc. (BIVN.O) said on Friday it has submitted an application to European regulators to market its experimental leukemia drug.
652006
A patient in the US is the first in the country to receive a implant device that automatically detects early symptoms of congestive heart failure.